•The Ares Capital and MidCap agreement has an implied value of about $2.6 billion.
•MidCap shareholders are expected to receive $10.88 per fully diluted share, including $1.21 in cash and about $9.67 in Ares shares before the special distribution adjustment.
•The consideration represents a 30.1% premium to MidCap’s October 26 closing price and a 25.8% premium to its 30-day volume-weighted average price.
•Intel shares closed down 28.6% on Friday, their steepest decline since 1974.
•Intel forecast fourth-quarter revenue of $15 billion to $16 billion and adjusted earnings of 25 cents a share, compared with estimates of $17.07 billion and 43 cents.
•An explosion at the Kiryat Gat plant cut the fourth-quarter revenue forecast by about $300 million and gross margin by about 200 basis points, with a similar impact expected in the first quarter.
•CorMedix shares closed at $7.64 on October 29, 2026.
•CorMedix estimated that the DefenCath add-on in 2027 could reach three to five times the level in the third and fourth quarters of 2026 if CMS used the same methodology.
•DaVita’s CFO expects the add-on to decline clearly from the first quarter to the second quarter of 2027.
•The company issued $950 million in senior unsecured notes bearing 8.750% interest and due in 2031.
•The company used the proceeds and cash to redeem notes due in 2028 and repay about $376.3 million of revolving borrowings and about $42.2 million of export financing.
•Revolving facility commitments increased from $2,486 million to $2,801 million, with maturity on January 22, 2030.
•The offer was priced at $7.35 per share, and its proponents said it included a premium of nearly 20% to the October 27, 2026 close.
•Blackwells said Trian would retain its 16.3% stake and that approval from four out of every ten shares unaffiliated with the group could be enough to complete the deal.
•Wendy’s shares closed at $7.17 on October 29, 2026.
•Scotiabank raised its offer from J$61.50 to J$75 per share on September 29, 2026.
•The revised price represented a premium of about 38% to the volume-weighted average price over 30 trading sessions through June 11, and 27% to the September 28 closing price.
•About 77% of participating minority shareholders voted in favor of the deal, representing about 97% of the common shares at the October 7 meeting.
•Average pay settlements in 2026 so far stood at 3.6%.
•2026 settlements fell to 3.6% from 4% in 2025.
•Companies expected wage growth of 3.4% over the next twelve months in the three months to September, with an expected decline of 0.6 percentage points.
•S&P kept Meta's rating at AA- and lowered its outlook from stable to negative.
•Meta expects capital spending of between $135 billion and $145 billion in 2026, compared with a previous range of between $130 billion and $145 billion.
•Meta posted negative free cash flow of $2.12 billion in the third quarter, with operating cash flow of $32.79 billion and capital spending of $34.91 billion.
